Multi-omics Analysis of Immune Determinants of STK11 in Non-Small Cell Lung Cancer

被引：0
|
作者：
Alhushki, S. K. [1 ]
Al-Muhtaseb, A. [2 ]
Abushukair, H. [3 ]
Abulrous, F. [4 ]
机构：
[1] Mutah Univ, Al Karak, Jordan
[2] Hashemite Univ, Zarqa, Jordan
[3] Jordan Univ Sci & Technol, Irbid, Jordan
[4] Henry Ford Hlth, Detroit, MI USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
STK11; Immunotherapy; Non-small Cell Lung Cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP03.03-02
引用
收藏
页码：S442 / S443
页数：2
相关论文
共 50 条
  • [21] Impact of STK11 and KRAS co-mutations on outcomes with immunotherapy in non-small cell lung cancer.
    Basher, Fahmin
    Saravia, Diana
    Fanfan, Dino
    Cotta, Jared Addison
    Lopes, Gilberto
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation.
    An, Josiah
    Yan, Melissa
    Yu, Nanmeng
    Chennamadhavuni, Adithya
    Furqan, Muhammad
    Kruser, Timothy
    Sita, Timothy L.
    Nguyen, Ryan
    Feldman, Lawrence Eric
    Pasquinelli, Mary
    Hanna, Nasser H.
    Abu Hejleh, Taher
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] Prognostic implications of STK11 with different mutation status and its relationship with tumor-infiltrating immune cells in non-small cell lung cancer
    Zheng, Jianqing
    Deng, Yujie
    Huang, Bifen
    Chen, Xiaohui
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [24] A Multi-Omics Network of a Seven-Gene Prognostic Signature for Non-Small Cell Lung Cancer
    Ye, Qing
    Falatovich, Brianne
    Singh, Salvi
    Ivanov, Alexey V.
    Eubank, Timothy D.
    Guo, Nancy Lan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (01)
  • [25] Impact of Concurrent STK11 Loss and c-MYC Amplification in Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Menon, S.
    Ellis, C.
    Poudel, S.
    Johnson, J.
    Szabo, A.
    George, B.
    Kelly, W. Kevin
    Grant, S.
    McPherson, J.
    Cristofanilli, M.
    Hoimes, C.
    Gutierrez, M.
    Doudement, J.
    Chan, L.
    Singal, G.
    Alexander, B.
    Miller, V.
    Sohal, D.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : S29 - S30
  • [26] Long duration of immunotherapy in a STK11 mutated/KRAS wild-type non-small cell lung cancer patient
    Domingues, I.
    Cedres, S.
    Callejo, A.
    Vivancos, A.
    Martinez-Marti, A.
    Felip, E.
    PULMONOLOGY, 2020, 26 (01): : 49 - 50
  • [27] Mutational landscape of STK11, PD-L1 expression, and TMB in patients with non-small cell lung cancer
    Jiang, Youhua
    Tao, Kaiyi
    Wang, Liang
    Hu, Yuqian
    Zhang, Shiyue
    Zhang, Lin
    Yao, Ming
    CANCER RESEARCH, 2020, 80 (16)
  • [28] Functional assessment of somatic STK11 variants identified in primary human non-small cell lung cancers
    Donnelly, Liam L.
    Hogan, Tyler C.
    Lenahan, Sean M.
    Nandagopal, Gopika
    Eaton, Jenna G.
    Lebeau, Meagan A.
    McCann, Cai L.
    Sarausky, Hailey M.
    Hampel, Kenneth J.
    Armstrong, Jordan D.
    Cameron, Margaret P.
    Sidiropoulos, Nikoletta
    Deming, Paula
    Seward, David J.
    CARCINOGENESIS, 2021, 42 (12) : 1428 - 1438
  • [29] Tumor-Derived Complement C3 as a Therapeutic Target in STK11 Mutant Non-Small Cell Lung Cancer
    Yau, E.
    Suzuki, S.
    Kandar, B.
    Ting, C.
    Giridharan, T.
    Stokolosa, A.
    Khan, A. N.
    Segal, B.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S86 - S86
  • [30] Loss of STK11 Suppresses Lipid Metabolism and Attenuates KRAS-Induced Immunogenicity in Patients with Non-Small Cell Lung Cancer
    Principe, Daniel R.
    Pasquinelli, Mary M.
    Nguyen, Ryan H.
    Munshi, Hidayatullah G.
    Hulbert, Alicia
    Aissa, Alexandre F.
    Weinberg, Frank
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (08): : 2282 - 2294
12345